Insider · CIK 0001943931
Simon Tarsh
Files at LNAI (RENOVARO INC.), ONCO (Onconetix, Inc.). First filing -, latest -.
In brief
Simon Tarsh files SEC Form 4 as CFO and director at LNAI (RENOVARO INC.), and also at ONCO (Onconetix, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Simon Tarsh has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | ONCO Onconetix, Inc. | JOther Common Stock | +39 | $0.00 | $0 | 40 | Aug 19, 2025 |
| Aug 15, 2025 | ONCO Onconetix, Inc. | AGrant or award Common Stock | +618 | $0.00 | $0 | 658 | Aug 19, 2025 |
| Nov 4, 2024 | LNAI RENOVARO INC. | AGrant or award Option to purchase shares of common stockderivative | +58,500 | $0.00 | $0 | 58,500 | Nov 6, 2024 |
Questions about Simon Tarsh
Answered from the filings on this page, as of the latest one.
Is Simon Tarsh buying or selling?
Simon Tarsh has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Simon Tarsh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Simon Tarsh has 0.
Where does Simon Tarsh file Form 4?
Simon Tarsh has filed Form 4 at LNAI (RENOVARO INC.) as Interim CFO; ONCO (Onconetix, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.